Optigenex Inc. (OPGX)

USD 0.0

(0.0%)

Operating Expenses Summary of Optigenex Inc.

  • Optigenex Inc.'s latest annual operating expenses in 2007 was 1.28 Million USD , down -65.08% from previous year.
  • Optigenex Inc.'s latest quarterly operating expenses in 2008 Q2 was 315.45 Thousand USD , up 8.93% from previous quarter.
  • Optigenex Inc. reported a annual operating expenses of 3.68 Million USD in annual operating expenses 2006, down -38.56% from previous year.
  • Optigenex Inc. reported a annual operating expenses of 6 Million USD in annual operating expenses 2005, up 33.46% from previous year.
  • Optigenex Inc. reported a quarterly operating expenses of 315.45 Thousand USD for 2008 Q2, up 8.93% from previous quarter.
  • Optigenex Inc. reported a quarterly operating expenses of 376.31 Thousand USD for 2007 Q2, down -6.31% from previous quarter.

Annual Operating Expenses Chart of Optigenex Inc. (2007 - 2004)

Historical Annual Operating Expenses of Optigenex Inc. (2007 - 2004)

Year Operating Expenses Operating Expenses Growth
2007 1.28 Million USD -65.08%
2006 3.68 Million USD -38.56%
2005 6 Million USD 33.46%
2004 4.49 Million USD 0.0%

Peer Operating Expenses Comparison of Optigenex Inc.

Name Operating Expenses Operating Expenses Difference
American Bio Medica Corporation 1.04 Million USD -22.771%
Arrayit Corporation 6.19 Million USD 79.22%
Atlantic International Corp. 5.57 Million USD 76.913%
Biocept, Inc. 29.4 Million USD 95.62%
Bioqual, Inc. 7.44 Million USD 82.71%
CardioGenics Holdings Inc 772.14 Thousand USD -66.792%
DermTech, Inc. 104.01 Million USD 98.762%
Global WholeHealth Partners Corporation - USD -Infinity%
Hangzhou Tigermed Consulting Co., Ltd. 166.5 Million USD 99.227%
HTG Molecular Diagnostics, Inc. 22.62 Million USD 94.307%
iMD Companies, Inc. 151.8 Thousand USD -748.348%
IDenta Corp. 662.97 Thousand USD -94.256%
Interpace Biosciences, Inc. 20.23 Million USD 93.634%
Integrative Health Technologies, Inc. 38.88 Thousand USD -3212.335%
InVitro International 661.32 Thousand USD -94.741%
Lumos Diagnostics Holdings Limited 7.09 Million USD 81.856%
Many Bright Ideas Technologies Inc. 58.11 Thousand USD -2116.184%
Medical Imaging Corp. 1.91 Million USD 32.649%
NovelStem International Corp. 3.53 Million USD 63.597%
PharmChem, Inc. 2.93 Million USD 56.064%
Proteome Sciences plc 3.26 Million USD 60.592%
Response Genetics, Inc 25.31 Million USD 94.913%
Rennova Health, Inc. 7.67 Million USD 83.226%
RushNet, Inc. 1.78 Million USD 28.025%
ScreenPro Security Inc. 3.23 Million USD 60.238%
Stella Diagnostics Inc. 11.42 Million USD 88.73%
StageZero Life Sciences Ltd. 7.34 Million USD 82.461%
Todos Medical Ltd. 14.05 Million USD 90.839%